ABI3 | ABI family, member 3 | | | | | | Tissue enhanced |
AC004017.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC007952.5 | Uncharacterized protein ENSP00000382042 | | | | | | Tissue enhanced |
AC007952.6 | Uncharacterized protein | | | | | | Tissue enhanced |
AC008964.1 | | | | | | | Tissue enhanced |
AC023590.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC103801.2 | | | | | | | Tissue enhanced |
AC104534.3 | Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | | | | | | Tissue enhanced |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
ADORA2A | Adenosine A2a receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
AIF1L | Allograft inflammatory factor 1-like | | | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | | | | | | Tissue enhanced |
AIRE | Autoimmune regulator | Disease related genes Transcription factors
| | | | | Tissue enhanced |
AL353354.2 | | Predicted secreted proteins
| | | | | Tissue enhanced |
AL359693.1 | | | | | | | Tissue enhanced |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
ANKRD18A | Ankyrin repeat domain-containing protein 18A | | | | | | Tissue enhanced |
ANKRD18B | Ankyrin repeat domain 18B | | | | | | Tissue enhanced |
ANXA2R | Annexin A2 receptor | | | | | | Tissue enhanced |
AP001350.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AP003733.1 | Uncharacterized protein; cDNA FLJ36460 fis, clone THYMU2014801 | | | | | | Tissue enhanced |
AP5B1 | Adaptor-related protein complex 5, beta 1 subunit | | | | | | Tissue enhanced |
APLNR | Apelin receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | | | | | | Tissue enhanced |
APOBEC3B | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | | | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ASTL | Astacin-like metallo-endopeptidase (M12 family) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ATAD5 | ATPase family, AAA domain containing 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
ATP8B4 | ATPase, class I, type 8B, member 4 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes
| | | | | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Transcription factors
| | | | | Tissue enhanced |
BCL2A1 | BCL2-related protein A1 | Cancer-related genes
| | | | | Tissue enhanced |
BFSP2 | Beaded filament structural protein 2, phakinin | Disease related genes
| | | | | Tissue enhanced |
BST1 | Bone marrow stromal cell antigen 1 | CD markers Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
C10orf105 | Chromosome 10 open reading frame 105 | | | | | | Tissue enhanced |
C11orf21 | Chromosome 11 open reading frame 21 | | | | | | Tissue enhanced |
C16orf54 | Chromosome 16 open reading frame 54 | Predicted membrane proteins
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | | | | | | Tissue enhanced |
C19orf35 | Chromosome 19 open reading frame 35 | | | | | | Tissue enhanced |
C19orf38 | Chromosome 19 open reading frame 38 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf228 | Chromosome 1 open reading frame 228 | | | | | | Tissue enhanced |
C1QTNF1-AS1 | C1QTNF1 antisense RNA 1 | | | | | | Tissue enhanced |
C21orf90 | Chromosome 21 open reading frame 90 | | | | | | Tissue enhanced |
C2orf48 | Chromosome 2 open reading frame 48 | | | | | | Tissue enhanced |
C5AR2 | Complement component 5a receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |